Crispr Therapeutics shares owned by CarsonAllaria Wealth Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by CarsonAllaria Wealth Management
from 13F filings
Historical chart of CarsonAllaria Wealth Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by CarsonAllaria Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by CarsonAllaria Wealth Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $17k | 368 | 46.98 |
| 2024-06-30 | $24k | 436 | 54.01 |
| 2024-03-31 | $30k | 436 | 68.16 |
| 2023-12-31 | $26k | 413 | 62.60 |
| 2023-09-30 | $20k | 437 | 45.39 |
| 2023-06-30 | $29k | 511 | 56.14 |
| 2023-03-31 | $24k | 520 | 45.23 |
| 2022-12-31 | $24k | 595 | 40.34 |
| 2022-09-30 | $43k | 660 | 65.15 |
| 2022-06-30 | $40k | 664 | 60.24 |
| 2022-03-31 | $39k | 614 | 63.52 |
| 2021-12-31 | $4.0k | 50 | 80.00 |
More positions owned by CarsonAllaria Wealth Management
View all positions for CarsonAllaria Wealth Management